Sartorius

3y

Sartorius, through its subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix from private investors. The Nottingham, UK-based company is a leader in the field of recombinant albumin-based solutions. Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies, viral therapies and vaccines.

Sartorius

3y

As Manager Talent Acquisition in Germany, Dennis Nautze interviews numerous candidates every week. What are the most important questions candidates should prepare for? Read Dennis’ recommendations and get an insight about which questions might be asked in an interview. The most important point: You will know best, what it is that you would like to share with us, but Dennis always suggests being yourself. Find more tips for a successful interview process on the Sartorius blog.

Sartorius

3y

Sartorius awarded the top graduates of the Faculty of Business and Economics at the Georg-August-Universität Göttingen with the Florenz Sartorius Award. Since 2010, the company has partnered with the university to recognize exceptional academic achievements with the award, which was named after the company’s founder due to his entrepreneurial spirit.

Sartorius

3y

Today, on World Hepatitis Day 2022, we're joining the World Health Organization in highlighting the need for providing people with better access to prevention, treatment and care for viral hepatitis. Sartorius is part of the solution in fighting hepatitis. Our technologies support customers to commercially produce the cell lines needed for type B vaccines and other recombinant protein vaccines.

Sartorius

3y

While Sartorius' main mission is to help scientists and engineers make advances in the life sciences, our products are being used time and again in extraordinary ways. The Apollo 11 mission in July 1969 marked the beginning of Sartorius’ involvement in several #space missions. Find out more about how samples of #moon rock were analyzed in Göttingen - and which of our instruments even made it to the International Space Station (#ISS).

Sartorius

4y

The life science group Sartorius increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.

Sartorius

4y

Sartorius opened its doors to more than 1,200 visitors during the fifth Night of Knowledge in Göttingen. They were able to take a look behind the scenes of life sciences and their accompanying technologies, took part in numerous guided tours on campus and attended various presentations – including on virtual reality, 3D printing, artificial intelligence and how these are used in our industry.

Sartorius

4y

In our series of application tips from all over the world, India is of course a must. Venkatesh Subramaniyan, Recruitment Specialist in Bangalore, reveals what candidates should look out for in their CV and how to design the document. Once this hurdle has been cleared, he has an additional tip for the job interview. Read the complete interview including further job application tips from other recruiters on the Sartorius blog.

Sartorius

4y

As part of Sartorius' university collaboration scheme in Tunisia, the M’hamdia team recently welcomed students from the Institute of Electrical and Electronical Engineering (IEEE) of the Tunis Faculty of Science again. Learn more about university cooperations in Tunisia and watch what the students have to say about their visit on the Sartorius blog.

Sartorius

4y

New jobs, new growth opportunities: In 2021, we welcomed a total of 4,381 new colleagues worldwide and created 3,195 new jobs. This growth provides opportunities for our people to advance their career. Join our team to #GrowWithUs: http://ow.ly/Fezf50Jxb2b